Rene Bernards - 02 Oct 2023 Form 4/A - Amendment Insider Report for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)

Role
Director
Signature
/s/ Rene Bernards
Issuer symbol
LIXT
Transactions as of
02 Oct 2023
Net transactions value
+$24,116
Form type
4/A - Amendment
Filing time
05 Oct 2023, 20:39:03 UTC
Date Of Original Report
04 Oct 2023
Previous filing
16 Dec 2022
Next filing
05 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIXT Common Stock Purchase $10,243 +4,473 +30% $2.29 19,473 02 Oct 2023 Direct F1
transaction LIXT Common Stock Purchase $13,873 +5,527 +28% $2.51 25,000 03 Oct 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person acquired an aggregate of 4,473 shares in numerous trades at prices ranging from $2.29-$2.40
F2 The Reporting Person acquired an aggregate of 5,527 shares in numerous trades ranging from $2.51-$2.58

Remarks:

This amended Form 4 corrects the amount of shares beneficially owned